Driven Brands Restates Three Years of Financials, Delays 10-Q, Cuts FY26 EBITDA Outlook
DRVN sits 25% above its 52-week low of $9.8.
Summary
Driven Brands will restate fiscal 2023-2025 and both 2026 quarters for fixed-asset accounting errors, miss its Q3 10-Q deadline, suspend buybacks, and cut FY2026 Adjusted EBITDA guidance to $410-430 million.
Key Events · Legal and Risk Events · DRVN
-
Three Years of Financials Restated
On October 31, 2026, the Audit Committee concluded that statements for fiscal 2023, 2024 and 2025 and the quarters ended March 28 and June 27, 2026 contain material errors and should not be relied upon; the auditor's report on those statements and on internal control is also no longer reliable.
-
Fixed-Asset Errors, Second Restatement
Errors center on failure to timely write off fixed assets (mainly sale-leaseback), misclassification within fixed asset categories, and incorrect useful lives. A prior restatement of fiscal 2023-2024 was disclosed February 23, 2026 and corrected in the 2025 10-K.
-
Q3 10-Q Deadline Missed
The company will not file its Form 10-Q for the quarter ended September 26, 2026 by the November 5, 2026 due date or within the Rule 12b-25 five-day extension, and intends to file a Form 12b-25 on or before November 6, 2026.
-
FY26 EBITDA Outlook Cut
Adjusted EBITDA guidance lowered to $410-430 million from $430-460 million and Adjusted Diluted EPS to $1.10-1.20 from $1.15-1.25; revenue and free cash flow of $125-145 million unchanged.
Analysis · DRVN · Trade & Services
The Audit Committee has concluded that financial statements for fiscal 2023, 2024 and 2025 — plus both 2026 quarters — contain material fixed-asset errors and cannot be relied upon, and the auditor's report on those statements and on internal control is likewise no longer reliable. This is the second restatement in under a year (a prior one was disclosed February 23, 2026 and corrected in the 2025 10-K), which makes the control problem look chronic rather than a one-off. The practical damage is concrete: the Q3 10-Q will not be filed by the November 5, 2026 deadline, the buyback is suspended until reporting is current, and restatement costs are now at least $50 million for 2026 versus the prior $35-45 million expectation. Management also cut FY2026 Adjusted EBITDA to $410-430 million from $430-460 million and EPS to $1.10-1.20 from $1.15-1.25, citing macro headwinds, pressure on lower-income customers at Take 5, Maaco and Collision, and the added restatement costs. The offset is that the errors are described as having a negligible impact on Adjusted EBITDA and cash generation remains intact — about $230 million of cash and $1.4 billion of net debt after roughly $485 million of debt repayment year-to-date. What keeps this from being a contained accounting fix is the open-ended timeline for completing the restatement and the risk of further errors or material weaknesses.
How filings like this one have moved
In the 30 days to Nov 3, 2026, 50.3% of the 199 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DRVN was trading at $12.27 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $9.80 to $17.30. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.